Concepts (209)
Concepts are derived automatically from a person's publications.
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
- 25-Hydroxyvitamin D3 1-alpha-Hydroxylase
- Academic Medical Centers
- Acute Disease
- Adenosine Monophosphate
- Adjuvants, Immunologic
- Adolescent
- Adrenal Cortex Hormones
- Adult
- Adverse Drug Reaction Reporting Systems
- Advisory Committees
- Age Distribution
- Age Factors
- Aged
- Aged, 80 and over
- Alanine
- Ambulatory Care Facilities
- Anti-Bacterial Agents
- Antibodies, Neutralizing
- Antibodies, Viral
- Antigens, Viral
- Antimicrobial Cationic Peptides
- Antiviral Agents
- Asymptomatic Diseases
- Behavioral Risk Factor Surveillance System
- Betacoronavirus
- Cardiotonic Agents
- Cardiovascular Diseases
- Case-Control Studies
- Child
- Child, Preschool
- Chromatography, Liquid
- Chronic Disease
- Clinical Laboratory Services
- Clinical Laboratory Techniques
- Clinical Trials as Topic
- Clinical Trials, Phase III as Topic
- Community-Acquired Infections
- Comorbidity
- Contact Tracing
- Continuity of Patient Care
- Coronavirus
- Coronavirus 229E, Human
- Coronavirus Infections
- Coronavirus OC43, Human
- Cost-Benefit Analysis
- Critical Care
- Cross Infection
- Cross-Sectional Studies
- DEAD Box Protein 58
- Delivery of Health Care
- Dementia
- Demography
- Diagnostic Tests, Routine
- Disease Outbreaks
- DNA Primers
- Dose-Response Relationship, Immunologic
- Double-Blind Method
- Drug Approval
- Drug Labeling
- Drug Prescriptions
- Drug-Related Side Effects and Adverse Reactions
- Emergencies
- Environmental Exposure
- Enzyme-Linked Immunospot Assay
- Ethics, Medical
- Family Characteristics
- Female
- Frailty
- Geriatric Assessment
- Global Health
- Glucosides
- Health Care Rationing
- Health Equity
- Health Facilities
- Health Knowledge, Attitudes, Practice
- Health Personnel
- Health Status Disparities
- Heart Failure
- Hemagglutination Inhibition Tests
- Homes for the Aged
- Hospital Mortality
- Hospitalization
- Humans
- Immunity, Cellular
- Immunity, Humoral
- Immunization
- Immunization Programs
- Immunization Schedule
- Immunization, Passive
- Immunogenicity, Vaccine
- Immunoglobulin G
- Incidence
- Infant
- Infant, Newborn
- Infection Control
- Infectious Disease Transmission, Professional-to-Patient
- Influenza A virus
- Influenza A Virus, H1N1 Subtype
- Influenza A Virus, H3N2 Subtype
- Influenza B virus
- Influenza Vaccines
- Influenza, Human
- Influenzavirus C
- Injections, Intramuscular
- Inpatients
| - Intensive Care Units
- Interferon-beta
- Interferon-gamma
- Laboratories
- Laboratories, Hospital
- Length of Stay
- Leukocytes, Mononuclear
- Linear Models
- Lipid A
- Logistic Models
- Long-Term Care
- Male
- Mass Spectrometry
- Medical Records
- Metapneumovirus
- Middle Aged
- Middle East Respiratory Syndrome Coronavirus
- Missouri
- Morbidity
- Myocardial Infarction
- Myocarditis
- Neuraminidase
- Nose
- Nursing Homes
- Otitis Media
- Outpatients
- Pandemics
- Paramyxoviridae Infections
- Patient Care
- Pediatric Obesity
- Personal Protective Equipment
- Personnel, Hospital
- Pharyngitis
- Pharynx
- Pneumonia
- Pneumonia, Viral
- Population Surveillance
- Practice Guidelines as Topic
- Practice Patterns, Physicians'
- Pregnancy
- Pregnancy Complications, Infectious
- Pregnancy Outcome
- Prevalence
- Prospective Studies
- Protein Disulfide-Isomerases
- Public Health
- Quality of Life
- Quarantine
- Randomized Controlled Trials as Topic
- Real-Time Polymerase Chain Reaction
- Receptors, Calcitriol
- Receptors, Immunologic
- Research Design
- Residential Facilities
- Resource Allocation
- Respiration, Artificial
- Respiratory Syncytial Virus Infections
- Respiratory Syncytial Virus Vaccines
- Respiratory Syncytial Virus, Human
- Respiratory Syncytial Viruses
- Respiratory System
- Respiratory Tract Diseases
- Respiratory Tract Infections
- Reverse Transcriptase Polymerase Chain Reaction
- Risk
- Risk Assessment
- Risk Factors
- RNA, Messenger
- RNA, Viral
- Safety-Based Drug Withdrawals
- Seasons
- Sensitivity and Specificity
- Sentinel Surveillance
- Seroconversion
- Seroepidemiologic Studies
- Severity of Illness Index
- Signal Transduction
- Social Determinants of Health
- Surveys and Questionnaires
- Symptom Assessment
- Telecommunications
- Tennessee
- Thrombocytopenia
- Thrombosis
- Time Factors
- T-Lymphocytes
- Treatment Outcome
- Triggering Receptor Expressed on Myeloid Cells-1
- United States
- United States Food and Drug Administration
- Vaccination
- Vaccination Coverage
- Vaccine Potency
- Vaccines, Attenuated
- Vaccines, Inactivated
- Vaccines, Synthetic
- Vasoconstrictor Agents
- Viral Fusion Proteins
- Viral Vaccines
- Virion
- Vitamin D
- Wisconsin
- Work
- Young Adult
|
Talbot's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(209)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(293)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_